Actinium Pharmaceuticals Announces Pipeline Expansion with Initiation of Clinical Trial of Actimab-M in Multiple Myeloma Pharmaceutical Investing
Q Biomed Joins With Oklahoma Medical Research Foundation And Rajiv Gandhi Centre For Biotechnology To Develop Liver Cancer Chemotherapeutic Biotech Investing
Immunovaccine's Lead Immuno-Oncology Candidate to Enter Investigator-Sponsored Phase 2 Clinical Trial in Ovarian Cancer in Combination With Approved Anti-PD-1 Drug Pharmaceutical Investing
AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™ Pharmaceutical Investing
Portola Pharmaceuticals Signs $150 Million Royalty Agreement with HealthCare Royalty Partners for Development and Commercialization of Andexanet Alfa Pharmaceutical Investing
Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico Pharmaceutical Investing
Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto Biotech Investing
Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development Pharmaceutical Investing
